Abstracts

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency

Background: Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged SARS-CoV-2 infection, but the immune defects that predispose to persistent COVID-19 remain incompletely understood. Methods: Participants enrolled in the POSt-VaccInaTIon Viral CharactEristics Study (POSITIVES), a prospective cohort study enrolling participants with confirmed SARS-CoV-2 infection. Participants were categorized based on the extent of…

Analysis of Emergent SARS-CoV-2 Antiviral Resistance and Its Association With Virologic Rebound

Background: Nirmatrelvir-ritonavir (N-R) and remdesivir (RDV) are SARS-CoV-2 antivirals that reduce the risk of hospitalization and progression to severe COVID-19. N-R and RDV resistance have been described previously, but the frequency and risk factors for emergent drug resistance remains unclear. Methods: We enrolled non-hospitalized participants with acute SARS-CoV-2 infection into the POSITIVES study, a prospective…

Phase I Study of Cabotegravir Long-Acting Injectable Formulations Supports ≥4-Monthly Dose Interval

Background: Long-acting cabotegravir (CAB) administered intramuscularly (IM) every 2 months (Q2M) is approved for HIV-1 prevention; CAB and rilpivirine administered IM monthly or Q2M is approved for HIV-1 treatment. To support less frequent dosing, we evaluated safety and pharmacokinetics (PK) of the approved CAB 200 mg/mL (CAB200) formulation administered subcutaneously (SC) with recombinant human hyaluronidase…

Doxy-PEP Associated With Declines in Chlamydia and Syphilis in MSM and Trans Women in San Francisco

Background: In October 2022, the San Francisco (SF) Department of Public Health disseminated guidelines through community and public health networks recommending doxycycline post-exposure prophylaxis (doxy-PEP) for men who have sex with men (MSM) and transgender women (TGW) with a history of sexually transmitted infections (STIs) or multiple sex partners. Doxy-PEP’s effect on population-level incidence of…

Carotid Inflammation on FDG-PET Is Associated With Lower Cognitive Function in Treated HIV Infection

Background: Studies investigating the relationship between cardiovascular disease (CVD) and cognition in people with HIV (PWH) have largely focused on CVD risk factors and cerebral small vessel disease. We examined the relationship between subclinical carotid arterial inflammation on 18F-fluorodeoxyglucose (FDG)-PET and cognitive function in PWH. Methods: ART-treated PWH at moderate to high CVD risk underwent…

Assessing the Contribution of Glial Activation to Cognitive Control and Declarative Memory in PWH

Background: Virally suppressed people with HIV (VS-PWH) demonstrate impaired cognitive control (CC; executive function) and declarative memory (learning and memory), subdomains of the NIMH Research Domain Criteria framework. Building on evidence supporting a microglial contribution to central nervous system complications in VS-PWH, we used [11C]DPA-713 with positron emission tomography (DPA-PET) to track the translocator protein…